Edesa Biotech, Inc.
EDSA$14M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaMARKHAM17 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jun 30, 2026
10dMarket Overview
Stock performance and key metrics
EDSA News
Catalyst Timeline
1 upcoming, 1 past
Phase 2Next
Phase 2 Results
Jun 30, 2026AI-detected
EDSA is preparing to initiate a Phase 2 clinical trial for a vitiligo treatment with an expected start in mid-2026.
Drug Pipeline
No drugs found in this phase.
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply